T
842.00
+0.24%
Close of 9 Nov 2026, in ILA
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$101.0m
FY2018FY2025
Net income
−$15.9m
FY2018FY2025
Free cash flow
−$9.4m
FY2018FY2025
Shareholders' equity
$90.9m
FY2018FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $101.0m | $59.3m | $45.6m | $43.9m | $33.1m | $84,096 | $62,950 | $14.1m |
| Gross profit | $32.4m | $20.5m | $15.1m | $15.3m | $9.9m | $25,765 | $17,620 | $3.8m |
| Research and development | $4.4m | $2.8m | $3.4m | $2.5m | $986,000 | $1,615 | $765 | — |
| Operating income | $8.4m | −$5.8m | $3.6m | $4.4m | $2.6m | $6,067 | $2,281 | −$293,399 |
| Net income | −$15.9m | −$6.5m | $3.2m | $3.6m | $1.6m | $2,543 | −$558 | −$809,835 |
| Diluted earnings per share | -0.13 | -0.06 | 0.03 | 0.04 | 0.01 | 0.00 | -0.00 | -0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | $206.0m | $108.2m | $344,460 | $209,230 | $195,730 | $94,420 | $76,487 | — |
| Cash and short-term investments | $32.8m | $10.1m | $39,791 | $14,216 | $58,912 | $4,273 | $2,392 | — |
| Total liabilities | $115.1m | $45.6m | $122,401 | $57,194 | $39,866 | $46,607 | $71,999 | — |
| Debt | $51.3m | $31.2m | $82,341 | $26,261 | $7,895 | $27,516 | $54,867 | — |
| Shareholders' equity | $90.9m | $62.6m | $222,059 | $152,036 | $155,863 | $47,813 | $4,488 | — |
| Shares outstanding | 123m | 108m | 109m | 89m | 117m | 62m | 110m | 110m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | $10.3m | $6.7m | $1.4m | $3,535 | $1.1m | $3,331 | −$879 | $244,012 |
| Capital spending | −$19.7m | −$13.4m | −$26.9m | −$43,566 | −$7.6m | −$4,646 | −$3,530 | −$1.3m |
| Free cash flow | −$9.4m | −$6.7m | −$25.4m | −$40,030 | −$6.5m | −$1,315 | −$4,409 | −$1.0m |
| Dividends paid | — | — | — | — | — | −$2,346 | −$7,885 | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.8m | $31.8m | $31.6m | $29.5m | $22.6m | $17.3m | $14.6m | $14.9m |
| Gross profit | $9.4m | $9.1m | $10.3m | $9.3m | $7.0m | $5.7m | $5.0m | $5.1m |
| Operating income | $8,000 | $1.2m | $2.2m | $3.1m | $1.6m | $1.5m | −$9.5m | $705,000 |
| Net income | −$1.1m | $3.4m | −$22.2m | $2.0m | $3.0m | $1.2m | −$9.5m | $487,000 |
| Diluted earnings per share | -0.01 | 0.03 | -0.18 | 0.02 | 0.02 | 0.01 | -0.09 | 0.00 |
| Cash from operations | $1.0m | — | $9.0m | — | $1.0m | — | $6.0m | — |
| Capital spending | −$2.0m | −$5.0m | −$5.0m | −$5.0m | −$3.0m | −$4.0m | −$3.0m | −$3.0m |
| Free cash flow | −$1.0m | — | $4.0m | — | −$2.0m | — | $3.0m | — |
| Total assets | $246.6m | $211.5m | $206.0m | $189.5m | $163.2m | $123.8m | $108.2m | $118.8m |
| Cash and short-term investments | $15.1m | $28.0m | $32.8m | $22.5m | $7.6m | $6.0m | $10.1m | $10.7m |
| Debt | $56.2m | $56.6m | $38.8m | $32.0m | $39.7m | $40.4m | $25.0m | $27.8m |
| Shareholders' equity | $134.9m | $116.0m | $90.9m | $110.8m | $78.1m | $63.0m | $62.6m | $70.6m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 32.0% | 312.9% | — |
| Operating income | 24.0% | 325.2% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 33.0% | 33.3% | 32.9% | — |
| Operating margin | 1.6% | 4.2% | 4.7% | — |
| Net margin | -14.0% | -6.2% | -4.9% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | -34.9 | -36.6 | 66.6 | 46.5 | 223.2 |
| Price to sales | 5.5 | 4.0 | 4.7 | 3.8 | 10.7 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.